8 completed. 8 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 8 |
| Phase 2 | 2 | Completed 2 |
Follow Hypertrophy: new trials by email Literature Review of Hypertrophy trials Research Report on Hypertrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effects of Mavacamten in Healthy Participants Mavacamten - Healthy Participants | Phase 1 | Completed | Bristol-Myers Squibb | 84 | 2023-02-20 | 2023-10-12 |
| MPN-RC 118 AVID200 in Myelofibrosis AVID200 - Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis | Phase 1 | Completed | John Mascarenhas | 21 | 2019-02-15 | 2023-02-10 |
| Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Laboratory Biomarker Analysis, Metformin Hydrochloride, Pharmacological Study - Anemia, Fatigue | Phase 1 | Completed | City of Hope Medical Center | 3 | 2017-09-07 | 2026-10-19 |
| High Fluence Light Emitting Diode-Red Light (LED-RL) in Human Skin LED-RL Phototherapy, Mock Therapy - Fibrosis, Scarring | Phase 1 | Completed | Jared Jagdeo, MD, MS | 60 | 2016-01-01 | 2017-03-31 |
| Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS) Valproic Acid, CT Scan, Blood Sample - ALPS, Hypersplenism | Phase 1 / Phase 2 | Completed | Koneti Rao | 6 | 2008-01-01 | 2013-03-21 |
| Resistance Training in Elderly protein drink, Resistance training - Sarcopenia, Atrophy | Phase 1 / Phase 2 | Completed | Maastricht University Medical Center | 26 | 2007-01-01 | 2015-09-23 |
| Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome Pyrimethamine - Autoimmune Disease, Lymphatic Disease | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 8 | 2003-07-01 | 2008-03-04 |
| Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome Fansidar (pyrimethamine and sulfadoxine) - Autoimmune Disease, Lymphoproliferative Disorder | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 8 | 2001-03-01 | 2008-03-04 |
Splenomegaly (5) · Lymphadenopathy (4) · Autoimmune Lymphoproliferative Syndrome (3) · Autoimmune Diseases (2) · Fibrosis (2) · Lymphoproliferative Disorders (2) · Anemia (1) · Atrophy (1) · Cardiomyopathy, Hypertrophic (1) · Cardiovascular Diseases (1) · Cicatrix (1) · Fatigue (1) · Fever (1) · Heart Diseases (1)
Pathological Conditions, Anatomical (8) · Pathological Conditions, Signs and Symptoms (8) · Hemic and Lymphatic Diseases (5) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Lymphatic Diseases (3) · Pathologic Processes (3) · Hematologic Diseases (2) · Lymphoproliferative Disorders (2) · Signs and Symptoms (2) · Aortic Stenosis, Subvalvular (1) · Aortic Valve Disease (1)
Pyrimethamine (2) · Blood Specimen Collection (1) · MYK-461 (1) · Metformin (1) · Quality of Life (1) · Resistance Training (1) · Ritonavir (1) · Sulfadoxine (1) · Surveys and Questionnaires (1) · Valproic Acid (1) · fanasil, pyrimethamine drug combination (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Bristol-Myers Squibb (1) · City of Hope Medical Center (1) · Jared Jagdeo, MD, MS (1) · John Mascarenhas (1) · Koneti Rao (1) · Maastricht University Medical Center (1)
United States (7) · Netherlands (1)
Jared Jagdeo, MD, MS (1) · John Mascarenhas, MD (1) · Koneti Rao, MD (1) · Luc JC van Loon, PhD (1) · Nitya Nathwani, MD (1) · Ronald Hoffman, MD (1) · Ruben Mesa, MD (1)
PMID 18459515, PMID 19106243, PMID 19146602, PMID 23077622, PMID 23590233, PMID 25485805, PMID 27484782, PMID 40643151
P01CA108671 (1)